Posted 3/25/2024
Scientists and clinicians whose discoveries have shaped the understanding of HIV disease will provide updates on the...
Posted 2/22/2024
There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four...
Posted 2/7/2024
Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a...
All News
Experimental MERS Treatment Deemed Safe in Phase I Clinical Trial
Posted 1/9/2018FREDERICK, Md. -- A small clinical study overseen by the National Institute of Allergy and Infectious Diseases (NIAID) with support from the Frederick National Laboratory for Cancer Research has found that an experimental treatment for Middle East Respiratory Syndrome (MERS), an illness for which there is no licensed vaccine or treatment, is safe and well-tolerated in healthy…
New Partnership Seeks to Increase Availability of Lifesaving Transplants
Posted 11/28/2017The Frederick National Laboratory for Cancer Research has entered into a new partnership with Fred Hutchinson Cancer Research Center that if successful, could improve current methods of donor selection and thereby make lifesaving transplant procedures more readily available for patients with leukemia, multiple myeloma, and other disorders.
For patients with blood disorders…
Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One
Posted 10/26/2017Scientists from two U.S. national laboratories, industry, and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources, and emerging biotechnologies to dramatically accelerate the discovery of…
Change in Leadership at the Frederick National Laboratory
Posted 10/26/2017RESTON, Va., Oct. 26, 2017 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, announced today that Ethan Dmitrovsky, M.D. was appointed President of subsidiary Leidos Biomedical Research, Inc. (Leidos Biomed) and Laboratory Director of the Frederick National Laboratory for Cancer Research (FNLCR). Dmitrovsky will succeed current President David…
Plasma Treatment for Severe Influenza Deemed Well-Tolerated in Clinical Study
Posted 9/27/2017The upcoming flu season is just around the corner, and an ongoing challenge for researchers has been how to best respond to cases of severe influenza in the event of an outbreak.
The Frederick National Laboratory for Cancer Research has helped the National Institute of Allergy and Infectious Diseases (NIAID) to coordinate a clinical trial to determine if immune plasma could…
New Webpage Brings Increased Visibility to Frederick National Laboratory Subcontracting Opportunities
Posted 8/31/2017A new webpage will now make it easier for small businesses and others to find and apply for Frederick National Laboratory for Cancer Research business opportunities.
The new solicitations page, which launched on the Frederick National Lab website August 31, is designed to bring increased visibility to business opportunities through a new, user-friendly platform that…
FNL’s Christine Fennessey Wins Prestigious Award for HIV Research
Posted 8/23/2017
Congratulations are in order for the Frederick National Lab’s Christine Fennessey, Ph.D., who was one of the recipients of the IAS/ANRS Lange-van Tongeren Prize for Young Investigators at the 2017 International AIDS Society Conference on HIV Science.
Each year, the International AIDS Society and the France Recherche Nord & Sud Sida-HIV Hépatites (ANRS) award the…
New National Cryo-EM Facility Provides Access to Cutting-Edge Technology for Cancer Research Community
National Cryo-Electron Microscopy FacilityPosted 8/14/2017Cancer researchers nationwide now have access to the latest technology in the field of cryo-electron microscopy (cryo-EM)—the study of protein structures at atomic resolution—at the Frederick National Lab for Cancer Research. The emerging technology comes at a time when the field of cryo-EM has the potential to revolutionize structural biology.
For many institutions, buying…
New HPV Serology Laboratory Aims to Standardize Assays and Contribute to Vaccine Implementation and Access
Posted 7/27/2017A new international initiative, led by scientists at the Frederick National Laboratory for Cancer Research and several other institutions, is being launched to provide expertise and leadership on the development, validation, and standardization of human papillomavirus (HPV) serology assays to be used in vaccine trials. HPV serology assays measure antibody responses following…
New HPV Serology Laboratory Aims to Standardize Assays and Contribute to Vaccine Implementation and Access
Posted 7/27/2017A new international initiative, led by scientists at the Frederick National Laboratory for Cancer Research and several other institutions, is being launched to provide expertise and leadership on the development, validation, and standardization of human papillomavirus (HPV) serology assays to be used in vaccine trials. HPV serology assays measure antibody responses following…
Media Inquiries
For all media related questions please contact:
Mary Ellen Hackett
Manager, Communications Office